Long-term worsening of bipolar disorder related with frequency of antidepressant exposure

Annals of Clinical Psychiatry

Volumn 23, Issue 3, 2011, Pages 186-192

  Strejilevich, Sergio A ^a   Martino, Diego J ^a   Marengo, Eliana ^a   Igoa, Ana ^a   Fassi, Guillermo ^a   Whitham, Elizabeth A ^b   Ghaemi, Nassir ^b  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Antidepressants; Bipolar disorder; Mood instability; Mood stabilizers; Switch

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; OUTCOME ASSESSMENT; OUTPATIENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; COMPARATIVE STUDY; HOSPITALIZATION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 83455170586     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Baldessarini RJ, Leahy L, Arcona S, et al. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv. 2007;58:85-91.
2. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry. 1979;36:555-559. (Pubitemid 9201187)
3. Wehr TA, Sack DA, Rosenthal NE, et al. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1988; 145:179-184. (Pubitemid 18058361)
4. Quitkin FM, Kane J, Rifkin A, et al. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. Arch Gen Psychiatry. 1981;38:902-907. (Pubitemid 11040135)
5. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol. 1980;13:156-167. (Pubitemid 10048336)
6. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle accelera tion: a controversy revisited. Am J Psychiatry. 1995; 152:1130-1138.
7. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry. 2000;61:804-808.
8. Young LT, Joffe RT, Robb JC, et al. Double-blind comparison of addition of a second mood stabilizer vs an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry. 2000;157:124-126. (Pubitemid 30027433)
9. Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001;158:906-912. (Pubitemid 32547620)
10. Altshuler L, Kiriakos L, Calcagno G, et al. The impact of antidepressants discontinuation versus anti-depressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry. 2001;62:612-616. (Pubitemid 32848165)
11. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163:232-239. (Pubitemid 44480842)
12. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356:1711-1722. (Pubitemid 46658703)
13. Harvey PD. Defining and achieving recovery from bipolar disorder. J Clin Psychiatry. 2006;67(suppl 9):14-18. (Pubitemid 44369650)
14. Ghaemi SN, Rosenquist KJ, Ko JY, et al. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry. 2004;161:163-165. (Pubitemid 38419324)
15. Mundo E, Cattaneo E, Russo M, et al. Clinical variables related to antidepressant-induced mania in bipolar disorder. J Affect Disord. 2006;92:227-230. (Pubitemid 44269309)
16. First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders - Clinical Version (SCID-CV). Washington, DC: American Psychiatric Press; 1996.
17. Ramos-Brieva JA, Cordero-Villafafila A. A new validation of the Hamilton Rating Scale for Depression. J Psychiatr Res. 1988;22:21-28.
18. Colom F, Vieta E, Martínez-Arán A, et al. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale [in Spanish]. Med Clin (Barc). 2002;119:366-371. (Pubitemid 35238074)
19. Martino DJ, Marengo E, Igoa A, et al. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study. J Affect Disord. 2009;116:37-42.
20. Peralta V, Cuesta M. Escala Clínica de Intensidad, Frecuencia y Duración del Tratamiento Psicofarmacológico (Escala IFD). Pamplona, Spain: Virgen del Camino Hospital; 2002.
21. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161:1537-1547. (Pubitemid 39201448)
22. Ghaemi SN, Wingo AP, Filkowski MA, et al. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand. 2008;118:347-356.
23. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry. 2001; 62:565-569. (Pubitemid 32703099)
24. Truman CJ, Goldberg JF, Ghaemi SN, et al. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2007;68:1472-1479. (Pubitemid 350073393)
25. Baldessarini RJ, Tondo L, Hennen J, et al. Is lithium still worth using? An update of selected recent research. Harv Rev Psychiatry. 2002;10:59-75. (Pubitemid 34263977)
26. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry. 2004;65:432-441.
27. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161-174. (Pubitemid 36268319)
28. Morselli PL, Elgie R, GAMIAN-Europe. GAMIAN-Europe/BEAM survey I - global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord. 2003;5:265-278. (Pubitemid 37009890)
29. Strejilevich S, Correa E. Costs and challenges of bipolar disorders: focus in the South American Region. J Affect Disord. 2007;98:165-167. (Pubitemid 46048918)
30. Gazalle FK, Andreazza AC, Ceresér KM, et al. Clinical impact of late diagnose of bipolar disorder. J Affect Disord. 2005;86:313-316. (Pubitemid 40780046)
31. Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry. 2002;63:985-991. (Pubitemid 35388056)